Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information


Waltham, USA
135 Beaver St., Suite 309
Waltham, MA, 02452


Chief Financial Officer
Vice President, Research
President and CEO
Board Member
Board Of Directors
Board Of Directors
Board Of Directors
Board of Directors
Show All People


TOTAL $23.7M
Series A, 12/2009
Series B, 11/2010
Private Equity, 3/2012
Lux Capital
Polaris Partners
Third Rock Ventures
Lighthouse Capital Partners
Series A, 2/2013
Lux Capital
Polaris Partners
Third Rock Ventures
Crown Venture Fund


Kala Pharmaceuticals

Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. The company’s proprietary mucus penetrating particle technology dramatically improves drug distribution and pharmacokinetics by uniformly coating the mucosal surface with biocompatible, drug-loaded particles. Kala’s formulations achieve high, sustained local drug concentrations with reduced systemic exposure and are delivered in a patient friendly format. The company’s research efforts have demonstrated successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eye, and cervicovaginal tract, enabling diverse product opportunities that target significant clinical unmet need. Kala is focused on advancing an internal pipeline of products through human proof-of-concept, while establishing R&D collaborations with select partners to improve products in their pipelines.

Recent Milestones



Kala Pharmaceuticals screenshot
Above: Kala Pharmaceuticals
Uploaded: 3/14/12


  1. Stealthy Kala Pharmaceuticals lands $2M ( [edit]
  2. Kala Pharmaceuticals collects $3M in new funds ( [edit]
  3. SEC ( [edit]
  4. Kala Pharmaceuticals Raises $11.5M in Series A Equity Financing ( [edit]
Edit This Page
Last Edited 1/13/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy